And that is what is frustrating. NGIO has a supposed valuation of almost 600 million without any Covid vaccine work, Generex owns 60 something percent of the company, they have Excellegan they are supposedly selling, the have the clinics supposedly going...
And they are only worth .169 a share.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links